fep blue glp-1 coverage 2025 Who Gets the Shot? Access by State GLP-1s and Obesity Coverage: Differing

For someone starting at 250 pounds, for example, this could mean the difference between losing 37 pounds with Semaglutide and 50 pounds with Tirzepatide

if the prevention trials confirm this, the "brain bonus" for our patients already on these medications for diabetes or weight management could be one of the most significant public health wins in recent memory

Regulatory Context: DSHEA and FTC Standards The dietary supplement industry, particularly products making weight management and metabolic support claims, has been under increased FDA scrutiny in recent years

In addition, in January 2025, Medicare announced it will include semaglutide products (Ozempic, Rybelsus, and Wegovy) in its second round of drug price negotiations, treating all three brands as a single drug due to their shared active ingredient.28 With negotiated prices set to take effect in 2027, this could significantly reduce costs for Medicare beneficiaries

While both cause similar issues, clinical trials show slightly lower rates of gastrointestinal problems with semaglutide

Front Endocrinol (Lausanne) (2021) 12:721198